Peptides & Intermediates

Based on the R&D and commercial application experience in the peptide industry, we achieve large-scale green production of drug peptides with synthetic biotechnology. We transform the production mode with technological innovation, support clients with a professional and sincere attitude in developing peptide drugs that treat various chronic diseases, and work with clients to tackle global health challenges.


Semaglutide (for R&D)  CAS#910463-68-2

Semaglutide (for R&D) CAS#910463-68-2

Tirzepatide (for R&D)  CAS#2023788-19-2

Tirzepatide (for R&D) CAS#2023788-19-2

Peptide Sequence (9-37) CAS#1169630-82-3

Semaglutide Intermediate(P29) 

Peptide Sequence (9-37) CAS#1169630-82-3  

Semagluitde Side Chain: tBuO-C18-Glu(AEEA-AEEA-OH)-OtBu CAS#1118767-16-0

Semagluitde Side Chain

tBuO-C18-Glu(AEEA-AEEA-OH)-OtBu CAS#1118767-16-0

Tirzepatide Side Chain

Tirzepatide Side Chain

tBuO-C20-Glu(AEEA-AEEA-OH)-OtBu CAS#1188328-37


Other Modified Side Chains

Other Modified Side Chains


Dipeptide

Dipeptide

AEEA Derivative

AEEA Derivative

Building Blocks

Building Blocks

Automatic Injection Pen - For Semaglutide, Insulin Degludec

Automatic Injection Pen 

For Semaglutide, Insulin Degludec

Reusable Injection Pen - For Liraglutide, Insulin, HGH

Reusable Injection Pen 

For Liraglutide, Insulin, HGH

Disposable Injection Pen - For GLP-1 Agonists, Insulin, HGH

Disposable Injection Pen

For GLP-1 Agonists, Insulin, HGH